Teva to Report First Quarter 2014 Financial Results on May 1, 2014
20 Mars 2014 - 3:00PM
Business Wire
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today
that it will release its first quarter 2014 financial results on
Thursday, May 1, 2014 at 7:00 a.m. ET.
Teva will host a conference call and live webcast on the same
day, at 8:00 a.m. ET to discuss its first quarter 2014 results and
overall business environment. A Question & Answer session will
follow this discussion.
In order to participate, please dial the following numbers (at
least 10 minutes before the scheduled start time): United States
and Canada 1-888-771-4371; International 1-847-585-4405; passcode:
36926391.
A live webcast of the call will also be available on Teva's
website at: www.tevapharm.com. Please log in at least 10 minutes
prior to the conference call in order to download the applicable
audio software.
Following the conclusion of the call, a replay of the webcast
will be available within 24 hours on the Company's website. The
replay can also be accessed until May 8, 2014, at 11:59 p.m. ET by
calling 1-888-843-7419 or 1-630-652-3042; passcode: 36926391#.
About Teva
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a leading
global pharmaceutical company, committed to increasing access to
high-quality healthcare by developing, producing and marketing
affordable generic drugs as well as innovative and specialty
pharmaceuticals and active pharmaceutical ingredients.
Headquartered in Israel, Teva is the world's leading generic drug
maker, with a global product portfolio of more than 1,000 molecules
and a direct presence in approximately 60 countries. Teva's
Specialty Medicines businesses focus on CNS, respiratory oncology,
pain, and women's health therapeutic areas as well as biologics.
Teva currently employs approximately 45,000 people around the world
and reached $20.3 billion in net revenues in 2013.
IR:Kevin C. Mannix, United States, 215-591-8912Ran
Meir, United States, 215-591-3033Tomer Amitai, Israel,
972 (3) 926-7656orPR:Iris Beck Codner, Israel, 972 (3)
926-7246Denise Bradley, United States, 215-591-8974
Teva Pharmaceutical Indu... (NYSE:TEVA)
Graphique Historique de l'Action
De Juil 2024 à Août 2024
Teva Pharmaceutical Indu... (NYSE:TEVA)
Graphique Historique de l'Action
De Août 2023 à Août 2024